Showing posts with label
editing DNA
.
Show all posts
Showing posts with label
editing DNA
.
Show all posts
Monday, January 12, 2026
Why we own BEAM Therapeutics - update January 2026
›
Beam Therapeutics (NASDAQ: BEAM) Updated Investment & Business Report – January 2026 Theme: Precision genetic medicine through base...
Friday, May 24, 2024
Editas Medicine and CRISPR Therapeutics are both gene-editing companies that focus on developing therapies using CRISPR-Cas9 technology.
›
Let’s explore their differences and where they stand in terms of DNA editing technology: Editas Medicine : Market Cap : Approximately $4...
›
Home
View web version
